# A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

> **NCT00811499** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 25 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** ARRY-371797, p38 inhibitor; oral
- **DRUG:** Placebo; oral
- **DRUG:** Placebo; oral

## Key facts

- **NCT ID:** NCT00811499
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12-16
- **Primary completion:** 2009-09-29
- **Final completion:** 2009-09-29
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811499, "A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00811499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*